MULLER, EUGENIO
 Distribuzione geografica
Continente #
EU - Europa 3.979
NA - Nord America 3.937
AS - Asia 3.689
Continente sconosciuto - Info sul continente non disponibili 677
SA - Sud America 366
AF - Africa 37
OC - Oceania 10
Totale 12.695
Nazione #
US - Stati Uniti d'America 3.753
GB - Regno Unito 1.309
SG - Singapore 1.117
CN - Cina 993
IT - Italia 620
DE - Germania 477
RU - Federazione Russa 378
VN - Vietnam 378
SE - Svezia 309
HK - Hong Kong 305
BD - Bangladesh 271
UA - Ucraina 243
BR - Brasile 238
IN - India 161
FR - Francia 146
KR - Corea 143
TR - Turchia 138
NL - Olanda 134
CA - Canada 125
IE - Irlanda 117
EU - Europa 90
FI - Finlandia 78
CO - Colombia 56
GR - Grecia 36
JP - Giappone 36
PL - Polonia 30
AR - Argentina 26
IQ - Iraq 26
DK - Danimarca 24
BE - Belgio 18
ID - Indonesia 18
MX - Messico 18
VE - Venezuela 17
SA - Arabia Saudita 16
PK - Pakistan 12
ZA - Sudafrica 10
EC - Ecuador 9
LT - Lituania 9
NP - Nepal 8
PH - Filippine 8
ES - Italia 7
JM - Giamaica 6
JO - Giordania 6
UZ - Uzbekistan 6
AU - Australia 5
CL - Cile 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KZ - Kazakistan 5
MY - Malesia 5
NO - Norvegia 5
PE - Perù 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CH - Svizzera 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
PY - Paraguay 4
TN - Tunisia 4
AZ - Azerbaigian 3
BH - Bahrain 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
EG - Egitto 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MN - Mongolia 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
DM - Dominica 1
DZ - Algeria 1
GD - Grenada 1
Totale 12.090
Città #
Southend 1.198
Singapore 621
Ashburn 355
Hong Kong 286
Santa Clara 286
San Jose 255
Beijing 228
Seattle 221
Jacksonville 204
Milan 201
Chandler 200
Dallas 180
Princeton 155
Wilmington 135
Dublin 116
Los Angeles 101
Council Bluffs 98
Ho Chi Minh City 98
Redmond 96
Hanoi 87
Bengaluru 86
Buffalo 85
Phoenix 84
Munich 83
Nanjing 81
Mountain View 75
New York 73
Toronto 68
Ann Arbor 66
Lauterbourg 65
Sakarya 62
Serra 62
Moscow 55
Boardman 50
Guangzhou 50
Andover 48
Bogotá 46
Frankfurt am Main 45
Des Moines 44
Shanghai 37
Athens 35
Dearborn 35
Cangzhou 33
Jinan 32
The Dalles 31
Tokyo 29
Woodbridge 29
Somerville 28
Chicago 27
Warsaw 27
Shenyang 26
Hefei 25
Houston 25
Tianjin 25
Columbus 24
Da Nang 23
Dong Ket 20
Hebei 19
Fairfield 18
Nanchang 18
São Paulo 18
Hangzhou 17
Brussels 16
Falls Church 16
Rome 16
Kiez 15
Montreal 15
Nürnberg 15
Seoul 15
Hanover 14
Ottawa 14
Sunnyvale 14
Changsha 13
Zhengzhou 13
Baghdad 12
Cinisello Balsamo 12
Haiphong 12
Lowell 12
Kunming 11
Verona 11
Atlanta 10
Belo Horizonte 10
Haikou 10
Medford 10
Naples 10
Redwood City 10
San Francisco 10
Shenzhen 10
Amsterdam 9
Eitensheim 9
Orem 9
San Diego 9
Turin 9
Bühl 8
Chennai 8
Fuzhou 8
Jiaxing 8
Lakewood 8
Lanzhou 8
Palermo 8
Totale 7.377
Nome #
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism 280
Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue : studies in the rat and dog 269
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats 265
Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients 252
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment 249
Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes 244
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats 242
Abuse of recombinant human growth hormone: studies in two different dog models 235
Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus 229
Muscolar expression of MGF, IGF-1Ea and myostatin in intact and hypofysectomized rats : effects of rhGH and testosterone alone or combined 223
Growth hormone response induced by a respiratory muscle endurance training in healthy subjects 216
Orexigenic effects of a growth hormone secretagogue and nitric oxide in aged rats and dogs: correlation with the hypothalamic expression of some neuropeptidergic/receptorial effectors mediating food intake 214
La transizione menopausale : un milieu biologico-endocrino che predispone alla neurodegenerazione 211
Menopausal transition : a possible risk factor for neurodegenerative events 208
Menopausal transition : a possible risk factor for neurodegenerative events 197
The Leukocyte Expression of CD36 and other Biomarkers: Risk Indicators of Alzheimer’s Disease 197
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 196
The leukocyte expression of CD36 is reduced in patients with Alzheimer disease and in early phase of dementia 195
Long-term effects on bone of postnatal immunization against GHRH in female and male rats 194
Neuropeptidi di Rilevanza Endocrina 193
Muscle expressions of MGF, IGF-IEa and myostatin in intact and hypophysectomized rats : effects of rhGH and testosterone alone or combined 191
The 5-HT 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task 189
Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on the field 188
Menopausal transition : a possible risk factor for brain pathologic events 188
The nitric oxide donor molsidomine antagonizes age-related memory deficits in the rat 186
Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat 186
Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary 184
The leukocyte expression of CD36 is reduced in patients with Alzheimer disease and an early phase of dementia 183
Growth hormone regulation of growth hormone-releasing hormone gene expression 183
Growth hormone variants : a potential avenue for a better diagnostic characterization of growth hormone deficiency in children 183
Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats 181
Metodo per la determinazione dell'attività somatotropa 180
Effects of a somatostatin infusion on circulating levels of adipokines in obese women 179
A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes 178
Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation 178
Menopausal transition : a possible risk factor for neurodegenerative events 175
Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet 174
Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death : a novel nonanticoagulant action 173
The leukocyte expression of CD36 is reduced in patients with Alzheimer disease and in early phase of dementia 166
Gender-, age-, body composition- and training workload-dependent differences of GH response to a discipline-specific training session in elite athletes: a study on the field 165
Hexarelin modulates the expression of growth hormone secretagogues receptor type1a mRNA at hypothalamic and pituitary sites 164
Anorexigenic postprandial responses of PYY and GLP1 to slow ice cream consumption : preservation in obese adolescents, but not in obese adults 164
Epinephrine mediates the growth hormone-releasing effect of galanin in infant rats 160
Maintenance of a Normal Meal-induced Decrease in Plasma Ghrelin Levels in Children with Prader-Willi Syndrome 159
Mechanisms of action of GH 159
Growth hormone abuse : Methods of detection 157
Somatostatin infusion withdrawal: studies in the acute and recovery phase of anorexia nervosa, and in obesity 156
Molsidomine antagonizes L-NAME-induced acquisition deficits in a recognition memory task in the rat 155
Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults 153
α2-Adrenergic stimulation enhances growth hormone secretion in the dog: a presynaptic mechanism? 153
DUAL GAMMA-AMINOBUTYRIC ACID CONTROL OF PROLACTIN SECRETION IN THE RAT 152
Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review 150
Dopamine reuptake inhibitors and dopamine releasers : differential effect on plasma prolactin in the rat 150
Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat 149
Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting 147
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats 144
GABA OF CNS ORIGIN IN THE RAT ANTERIOR-PITUITARY INHIBITS PROLACTIN SECRETION 144
Long-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd) mutant mouse 142
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) autocrine/paracrine mechanisms 139
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa 137
GABAERGIC CONTROL OF ANTERIOR PITUITARY HORMONE SECRETION 137
The GABAB receptor and recognition memory: possible modulation of its behavioral effects by the nitrergic system 136
Neuroendocrine control of growth hormone secretion 134
Human pancreatic growth hormone (GH)-releasing hormone stimulates GH synthesis and release in infant rats. An in vivo study 129
Pharmacological manipulations of alpha-adrenoceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanisms of action 127
Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment 123
Effect of agonists and antagonists of cholinergic neurotransmission on growth hormone release in the dog 121
Falsi miti : l'effetto anabolizzante del GHB 121
Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats 115
In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups : ontogenetic development of their effect on GH release and synthesis 112
Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia 108
Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium 105
Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons 74
Totale 12.695
Categoria #
all - tutte 32.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022606 49 7 5 17 33 30 67 34 70 96 41 157
2022/2023874 94 38 48 107 121 193 21 60 141 5 31 15
2023/2024480 17 47 17 32 139 14 11 38 12 16 71 66
2024/20251.679 47 149 14 124 289 51 77 132 59 118 143 476
2025/20263.749 394 129 454 211 377 213 494 168 364 334 284 327
2026/2027181 181 0 0 0 0 0 0 0 0 0 0 0
Totale 12.695